Company / Interest Expense per Share
Astria Therapeutics, Inc. Interest Expense per Share History
FY2015-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.02
FY2018
5-year range
-
FY2015-FY2018
Trend
-90.7%
vs FY2017
Sector context
#37 of 43
Health Care
What the data says
Astria Therapeutics, Inc.'s interest expense per share of $0.02 is lower than 86% of companies in the Health Care sector (FY2018). Improved from $0.05 to $0.02 over the past 2 years.
Based on SEC 10-K filings.
0.02 in FY2018 with a 3-year CAGR of -45.4%.
Improved from $0.05 to $0.02 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -45.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 14% in Health CareTop 14% of 43This company $0.02 Sector average $18.61
▼
-99.9% below sector average
Key checks
Key Insights
- In FY2018, interest expense per share decreased 90.7% year-over-year.
- Ranks #37 out of 43 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 5.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | $0.02 | -90.7% |
| FY2017 | $0.21 | +313.2% |
| FY2016 | $0.05 | -57.6% |
| FY2015 | $0.12 | -74.9% |
As of FY2018 · SEC 10-K · Updated Feb 28, 2026